STOCK TITAN

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2022 Results Presentation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on March 1, 2023, at 4:30 p.m. ET. This event will review the company's business performance for Q4 and the full year ending December 31, 2022. Details regarding the presentation and a link to the webcast will be available on Ginkgo's investor relations website. Investors can submit questions via Twitter or email prior to the event. Ginkgo Bioworks focuses on cell programming and biosecurity solutions across various industries including food, pharmaceuticals, and public health.

Positive
  • Scheduled presentation indicates transparency and engagement with investors.
  • Focus on diverse markets can lead to growth opportunities.
Negative
  • No specific financial metrics or performance indicators were provided.

Presentation and Q&A session scheduled for post-market on Wednesday, March 1, 2023

BOSTON, Feb. 22, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2022, on Wednesday, March 1, 2023, beginning at 4:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com/events, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2022-results-presentation-301752784.html

SOURCE Ginkgo Bioworks

FAQ

What date is Ginkgo Bioworks' presentation on business performance?

Ginkgo Bioworks' presentation is scheduled for March 1, 2023.

What will be covered in the Ginkgo Bioworks presentation?

The presentation will review business performance for Q4 and the full year ended December 31, 2022.

How can I submit questions for the Ginkgo Bioworks presentation?

Questions can be submitted via Twitter using the hashtag #GinkgoResults or by emailing investors@ginkgobioworks.com.

Where can I find the webcast link for Ginkgo Bioworks' presentation?

The webcast link will be available on Ginkgo's investor relations website.

What time is the Ginkgo Bioworks presentation scheduled?

The presentation is scheduled to begin at 4:30 p.m. ET.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

409.25M
42.27M
6.15%
68.55%
13.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON